Investing Profile

Ian Peikon

InvestorVC
Venture Partner at Lux Capital
Photo of Ian Peikon, Venture Partner at Lux Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Duke University Network
274 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Lux Capital Network
28 CONNECTIONS
cb
Lux Capital Venture Partner
$1M - $50.0M
$10.0M
2
$1.5B
CompanyStageDateRound SizeTotal Raised
Cajal Neuroscience
Series ANov 2022$96M
SeedJan 2020
$96M
Co-investors: Tim Kutzkey (The Column Group), Josh Wolfe (Lux Research), Adam Goulburn (6 Dimensions Capital)
Board Member PlexiumPresent
Co-Founder & Chief Scientific Officer Cajal TherapeuticsPresent
Co-Founder & Director, Platform Biology & Technology KallyopePresent
Co-Founder & SAB Member Stromedix Inc.Present
Venture Partner Lux CapitalPresent
Co-Founder & Co-Chief Executive Officer Cajal TherapeuticsPresent
Duke University BSE Biomedical Engineering
Cold Spring Harbor Laboratory PhD Biological Sciences
Sign in with Google →
Sign in with Google →